Severe Eczema Drug Is Approved by F.D.A.; Price Tag Is $37,000 a Year

Thursday, March 30, 2017 - 05:41 in Mathematics & Economics

The drug makers Regeneron Pharmaceuticals and Sanofi made a rare move, negotiating with insurers in advance over the price for Dupixent.

Read the whole article on NY Times Health

More from NY Times Health

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net